Generic:

Montelukast
sodium

Therapeutic
Class:

Antileuk Anti-Asthm Sys

Composition:

Lucast 4 mg Sachet:
Each sachet contains Montelukast 4 mg (as sodium salt).

Lucast 4 mg Tablets:
Each chewable tablet contains Montelukast 4 mg (as sodium salt).

Lucast 5 mg Tablets:
Each chewable tablet contains Montelukast 5 mg (as sodium salt).

Lucast 10 mg Tablets:
Each tablet contains Montelukast 10 mg (as sodium salt).

Description:

Lucast
contains montelukast sodium, a relatively new and effective therapy
recommended by international and national guidelines for the control
(prevention) of acute and chronic asthmatic attacks.

Indications:

Asthma:

Lucast
is indicated for the prophylaxis and chronic treatment of
asthma in adults and pediatric patients 12 months of age and older.

Allergic Rhinitis:

Lucast
is indicated for the relief of symptoms of:

• Seasonal allergic rhinitis in patients 2 years of age and older
• Perennial allergic rhinitis in patients 6 months of age and older.

Exercise-Induced Bronchoconstriction (EIB):

Lucast
is indicated for prevention of exercise-induced bronchoconstriction (EIB)
in patients 6 years of age and older.

Dosage:

Asthma:

Lucast
should be taken once daily in the evening. The following doses are
recommended:

For
adults and adolescents 15 years of age and older: One Lucast 10 mg tablet.

For
pediatric patients 6 to 14 years of age: One
Lucast 5 mg chewable tablet.

For
pediatric patients 2 to 5 years of age: One
Lucast 4 mg chewable tablet or one Lucast 4 mg sachet.

For
pediatric patients 12 to 23 months of age: One Lucast 4 mg sachet.

Safety
and effectiveness in pediatric patients less than 12 months of age with
asthma have not been established.

Allergic Rhinitis:

For
allergic rhinitis, Lucast should be taken once daily.

Seasonal
allergic rhinitis

The
following doses for the treatment of symptoms of seasonal allergic rhinitis
are recommended:

For
adults and adolescents 15 years of age and older: One Lucast 10 mg tablet.

For
pediatric patients 6 to 14 years of age: One Lucast 5 mg chewable tablet.

For
pediatric patients 2 to 5 years of age: One Lucast 4 mg chewable tablet or One Lucast 4 mg
sachet.

Safety
and effectiveness in pediatric patients younger than 2 years of age with
seasonal allergic rhinitis have not been established.

Perennial
allergic rhinitis

The
following doses for the treatment of symptoms of perennial allergic
rhinitis are recommended:

For
adults and adolescents 15 years of age and older: One Lucast 10 mg tablet.

For
pediatric patients 6 to 14 years of age: One Lucast 5 mg chewable tablet.

For
pediatric patients 2 to 5 years of age: One Lucast 4 mg chewable tablet or One Lucast 4 mg
sachet.

For
pediatric patients 6 to 23 months of age: One Lucast 4 mg sachet.

Safety
and effectiveness in pediatric patients younger than 6 months of age with
perennial allergic rhinitis have not been established.

Asthma and Allergic Rhinitis:

Patients
with both asthma and allergic rhinitis should take only one Lucast dose
daily in the evening.

Exercise-Induced Bronchoconstriction (EIB):

For
prevention of EIB, a single dose of Lucast should be taken at least 2 hours
before exercise. The following doses are recommended:

For
adults and adolescents 15 years of age and older: One Lucast 10 mg tablet.

For
pediatric patients 6 to 14 years of age: One Lucast 5 mg chewable tablet.

An
additional dose of Lucast should not be taken within 24 hours of a previous
dose. 

Presentations:

• 4   mg   Sachet 14’s
• 10 mg   Tabs 10’s
• 5   mg   Tabs 10’s
• 4   mg   Tabs 14’s